Q2 2018 Holdings
Filed 2018-08-14 | 114 holdings | $292.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $54.8M | 2,745,705 | 18.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $37.0M | 447,029 | 12.7% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $34.7M | 6,063,496 | 11.9% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $32.1M | 482,467 | 11.0% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $30.3M | 741,016 | 10.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $29.5M | 350,000 | 10.1% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $21.0M | 2,305,773 | 7.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $16.7M | 729,948 | 5.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $14.4M | 146,000 | 4.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $12.9M | 3,491,922 | 4.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $6.7M | 250,000 | 2.3% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $130.4K | 6,988,248 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $109.5K | 6,609,894 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $106.6K | 5,227,035 | 0.0% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $94.9K | $99,100,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $64.1K | 1,300,365 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $63.0K | 1,742,111 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $57.5K | 1,159,000 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $56.7K | 2,573,305 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $55.9K | 2,900,000 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $55.4K | $75,000,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $54.7K | 1,126,800 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $54.6K | 1,446,633 | 0.0% |
| Xeris Pharmaceuticals Inc | COM | 98422L107 | $47.4K | 2,498,666 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $45.5K | 191,000 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $42.0K | 229,000 | 0.0% |
| Wright MED Group N V | NOTE 2.250%11/1 | 98236JAB4 | $41.9K | $31,500,000 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $41.5K | 1,158,841 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $40.1K | 1,048,430 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $40.0K | 562,989 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $40.0K | 324,536 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $39.1K | 296,000 | 0.0% |
| Endologix Inc | NOTE 3.250%11/0 | 29266SAB2 | $38.2K | $40,500,000 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $38.2K | 1,020,000 | 0.0% |
| CVS Health Corp(CVS)Call | COM | 126650100 | $36.5K | 566,800 | 0.0% |
| Trinity Biotech Invt LTD | NOTE 4.000% 4/0 | 89643QAB4 | $35.4K | $43,000,000 | 0.0% |
| CVS Health Corp(CVS) | COM | 126650100 | $35.4K | 550,000 | 0.0% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $33.7K | 1,858,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $32.7K | 484,055 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $32.5K | 233,000 | 0.0% |
| Endocyte Inc | COM | 29269A102 | $32.1K | 2,324,299 | 0.0% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $31.9K | 531,000 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $31.6K | $36,000,000 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $30.7K | 754,222 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $30.2K | 474,950 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $29.9K | $27,600,000 | 0.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $29.2K | 262,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $26.6K | 1,124,800 | 0.0% |
| K2m Group Hldgs Inc | NOTE 4.125% 8/1 | 48273JAB3 | $26.0K | $20,000,000 | 0.0% |
| DFB Healthcare Acquistion Co | UNIT 01/30/2023 | 23291E208 | $25.4K | 2,500,000 | 0.0% |